Rite Aid will be the first partner in a pilot test at 100 drugstores.
News & Analysis: Rite Aid
Despite the company's weaker-than-expected first quarter, its new partnership with Amazon has investors feeling optimistic.
Shares of the pharmacy chain jumped on renewed hopes for an acquisition.
The market was none too pleased about the pharmacy retail chain's progress last quarter.
The negative impact of the pharmacy retailer's disappointing Q4 update last week continued to weigh on the stock.
The long-struggling pharmacy chain's earnings show the company still has a tough road ahead of it.
Investors approved a move that should keep it on the New York Stock Exchange, but shares have now lost more than 90% of their value over the last three years.
Shares drop by double-digits after the company announced the termination of a merger agreement. Here's what investors need to know.
Shares crater after management pours cold water on its targets for the fiscal year. Here's what investors need to know.
Shares of the drugstore chain rose in anticipation of its merger vote with Albertson's.
The drugstore chain has given up value as the company has been unable to seal its merger with Albertson's.